Health Care & Hospitals

Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with…

A Cell-Surface Protein Provides Key to Infection BRONX, N.Y., Sept. 24, 2025 /PRNewswire/ — The protein on human cells…

AUSTIN, Texas and TOKYO, Sept. 19, 2025 /PRNewswire/ — According to DataM Intelligence, the global sleep aids market…

DELRAY BEACH, Fla., Sept. 19, 2025 /PRNewswire/ — The global In Vitro Diagnostics Quality Control Market, valued at…

Updated guideline based on the latest evidence-based recommendations ROSEMONT, Ill., Aug. 28, 2025 /PRNewswire/ — The American Academy…

SAN FRANCISCO, Aug. 25, 2025 /PRNewswire/ — Barti Software, a leading AI-powered company that provides innovative electronic health records…

Collaboration Extends Global Reach of High-Performance Genomic Sequencing on the UG 100™ Platform FREMONT, Calif. and HOUSTON, Aug.…

First Breakthrough Therapy Designation in the U.S. for SystImmune and Bristol Myers Squibb’s Izalontamab brengitecan (Iza-bren) based on data…

National campus campaign offers genetic screening, kosher comfort food, and educational outreach just in time for Back-to-School and Tay-Sachs…

NEW BRIGHTON, Minn., Aug. 4, 2025 /PRNewswire/ — Nystrom & Associates, a leading provider of behavioral health services,…

CHICAGO, Aug. 4, 2025 /PRNewswire/ — EVERSANA®, a leading provider of commercialization services to the global life sciences industry,…

Lilly’s Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer’s disease